Fieldpoint Private Securities’s Qiagen QGEN Stock Holding History

Fieldpoint Private Securities’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2K	Hold	37	–	–	﹤0.01%	1228
2022 Q1	$2K	Hold	37	–	–	﹤0.01%	1503
2021 Q4	$2K	Hold	37	–	–	﹤0.01%	1501
2021 Q3	$2K	Buy	+37	New	+$2.06K	﹤0.01%	1497

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fieldpoint Private Securities's QGEN Position: Q2 2022 in Review

Fieldpoint Private Securities held its Qiagen (QGEN) position steady in Q2 2022 at 37 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1228.

Fieldpoint Private Securities first reported a position in QGEN in Q3 2021 and has held it in 4 quarters since. 288 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

Fieldpoint Private Securities held 37 shares of Qiagen worth $2K as of Q2 2022.
Fieldpoint Private Securities left its Qiagen share count unchanged in Q2 2022.
Qiagen made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #1228 holding.
Fieldpoint Private Securities first reported a position in Qiagen in Q3 2021 and has held it in 4 quarters since.
288 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.